SCHEMBL13675193

SCHEMBL13675193

Cc1cc(Nc2ncnc3nc(Nc4ccc(CN5CCC(CN)CC5)cc4)sc23)ccc1F

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.65
AXL P30530 1/20 0.41
FLT1 P17948 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13672624 0.91 EGFR (0.79) EGFRAXL
SCHEMBL13675158 0.89 EGFR (0.81) EGFRAXL
SCHEMBL14462157 0.89 EGFR (0.63) EGFRFLT1
SCHEMBL13674980 0.88 EGFR (0.82) EGFRAXL
SCHEMBL13674979 0.87 EGFR (0.70) EGFRAXL
SCHEMBL13675194 0.87 EGFR (0.70) EGFRAXL
SCHEMBL13675161 0.86 EGFR (0.82) EGFRAXL
SCHEMBL13674982 0.81 EGFR (0.62) EGFR
SCHEMBL13675165 0.79 EGFR (0.71) EGFR
SCHEMBL13672611 0.79 EGFR (1.00) EGFRAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605154-B2 ATP-protein kinase inhibitors; cytomegalovirus; contraceptive agents; cancer; N7-(3-ethynyl-phenyl)-N2-(4-piperidin-1-ylmethyl-phenyl)-thiazolo[4,5-d]pyrimidine-2,7-diamine JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-20 US disclosed